Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Alphala patents anticancer compounds

May 14, 2021

New METTL3 inhibitors identified at Accent Therapeutics

May 14, 2021

Dosing begins in phase II trial of onapristone and anastrozole in endometrial cancer

May 13, 2021

New Angex Pharmaceutical anticancer compounds show preclinical potential

May 13, 2021

ShanghaiTech University, Fudan University patent new PROTACs

May 13, 2021

Suzhou Raymon Pharmaceuticals discovers PI3K-alpha inhibitors

May 13, 2021

Galectin-3 mediates the crosstalk between the WNT and STAT3 signaling pathways in gastric cancer

May 13, 2021

Phase IIb trial investigates ABTL-0812 with FOLFIRINOX in pancreatic cancer

May 12, 2021

Dose expansion begins in phase I/II study of darovasertib and crizotinib in MUM

May 12, 2021

New FGFR inhibitors presented by Incyte

May 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...